MedTech News
.................... by Andrew Celentano
New potential gene-based treatment for sepsis and lung injury
A new discovery from the lab of YouYang Zhao, Ph.D., from Stanley Manne Children’s Research Institute at Ann & Robert H. Lurie Children’s Hospital of Chicago, opens promising new directions for treatment of life-threatening lung injury caused by sepsis.
Novel imaging approach may improve treatment for spinal cord injuries
Northwestern Medicine investigators have developed a new imaging approach to more accurately assess blood flow in the spinal cord, a method that could be used to better inform treatment for neurological diseases and injuries, as described in a recent study published in Scientific Reports.
Supercomputer simulation is changing how we study the brain
Harnessing the muscle of one of the world’s fastest supercomputers, researchers have built one of the largest and most detailed biophysically realistic brain simulations of an animal ever.
Healing the heart after a heart attack with a biodegradable patch
A new patch developed by Texas A&M University researcher Dr. Ke Huang may offer a way to help the heart heal after a heart attack. The patch uses a unique microneedle system to deliver a therapeutic molecule directly to damaged heart tissue, promoting repair and improving heart function without affecting the rest of the body.
Precision therapy could stop breast cancer at the source
Researchers at the University of California San Diego School of Medicine have identified a promising new therapy for triple-negative breast cancer (TNBC), which is among the most aggressive and difficult-to-treat forms of the disease.
CRISPR breakthrough reverses chemotherapy resistance in lung cancer
In a major step forward for cancer care, researchers at ChristianaCare’s Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy resistance in lung cancer. The approach restores drug sensitivity and slows tumor growth. The findings are published in the journal Molecular Therapy Oncology.
Gene ‘switch’ reverses Alzheimer’s risk in experimental model
University of Kentucky researchers have developed a new experimental model that could point the way toward more effective Alzheimer’s disease treatments by targeting one of the brain’s most important genes for risk and resilience.
Zavation Medical Products Announces First Implantations of Varisync® ALIF NanoPrime™
FLOWOOD, Miss., Nov. 15, 2025 /PRNewswire/ — Zavation Medical Products, LLC (“Zavation”), a leading innovator in spinal device technology, announces the first successful implantations of the Varisync® ALIF NanoPrime™ System, a next-generation stand-alone ALIF system featuring Zavation’s proprietary titanium ion bond technology.